{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-197362","form_type":"8-K","ticker":"ELV","cik":"0001156039","company_name":"Elevance Health, Inc.","filed_at":"2022-07-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:55.088975+00:00","generated_at":"2026-06-24T10:58:35.238219+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Elevance Health Q2 2022: Adj. EPS $8.04, revenue +15.6% to $38.5B; raises FY outlook","bullets":["GAAP EPS $6.79; adjusted EPS $8.04, up 14.4% YoY.","Operating revenue $38.5B, up 15.6% YoY; operating gain $2.4B, up 13.7%.","Medical enrollment grew 2.7M members YoY to 47.1M; up 276K in quarter.","Full-year adjusted EPS guidance raised to >$28.70, from prior >$28.25.","Q3 dividend of $1.28/share declared; repurchased 1.3M shares for $624M."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-197362","json":"https://secwatch.observer/filing/0001193125-22-197362.json","markdown":"https://secwatch.observer/filing/0001193125-22-197362.md","text":"https://secwatch.observer/filing/0001193125-22-197362.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1156039/000119312522197362/0001193125-22-197362-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1156039/000119312522197362/d383286d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T10:58:35.238219+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}